sr141716 has been researched along with flupenthixol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trezza, V; Vanderschuren, LJ | 1 |
| Baarendse, PJ; Trezza, V; Vanderschuren, LJ | 1 |
| Hearing, MC; Huffington, ED; Ingebretson, AE; Thomas, MJ | 1 |
3 other study(ies) available for sr141716 and flupenthixol
| Article | Year |
|---|---|
Bidirectional cannabinoid modulation of social behavior in adolescent rats.
Topics: Analgesics, Opioid; Animals; Benzamides; Benzoxazines; Cannabinoids; Carbamates; Dopamine; Dopamine Antagonists; Exploratory Behavior; Flupenthixol; Male; Morphine; Morpholines; Motor Activity; Naloxone; Naphthalenes; Narcotic Antagonists; Piperidines; Play and Playthings; Pyrazoles; Rats; Rats, Wistar; Receptors, Dopamine; Reward; Rimonabant; Social Behavior | 2008 |
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior | 2009 |
Endogenous dopamine and endocannabinoid signaling mediate cocaine-induced reversal of AMPAR synaptic potentiation in the nucleus accumbens shell.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Antagonists; Cocaine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Endocannabinoids; Flupenthixol; Long-Term Synaptic Depression; Male; Mice; Morpholines; Naphthalenes; Nucleus Accumbens; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rimonabant; Synaptic Transmission | 2018 |